-
Dec 5, 2024 | 
drugtopics.com | Lauren Massaro
The COVID-19 pandemic instilled in many people a greater awareness of health and well-being. But with physicians’ offices closed and health care professionals overwhelmed, the internet emerged as a central resource for all things health—often replacing typical provider guidance. It became one of the first places people learned about stay-at-home orders, vaccine developments, and quarantine updates.
-
Nov 22, 2024 | 
drugtopics.com | Lauren Massaro |James Rider
By the age of 16, James Rider, PharmD, CVS Pharmacy Manager in Winston-Salem, North Carolina, knew that he wanted to become a pharmacist. From his first experience at Revco drug store—which was ultimately acquired by CVS—to his career path leading him to work as a pharmacy manager, Rider discussed what he’s most passionate about in the pharmacy and how rewarding his profession has been. “It's very demanding, of course, but you have an opportunity to help everybody on an individual level.
-
Nov 21, 2024 | 
drugtopics.com | Lauren Massaro |James Rider
James Rider, PharmD, is a seasoned pharmacy professional whose journey began in the aisles of a local drugstore. “I started in pharmacy when I was 16 years of age,” Rider said in an interview with Drug Topics for American Pharmacists Month.“My parents bought me a car, and they said, ‘Son, you have to get out and get a job.’ So, I went looking for a job, and I stumbled across a Revco store looking for help.
-
Nov 19, 2024 | 
drugtopics.com | Lauren Massaro
Due to his early interests in both mathematics and medicine, Adam J. James’ career aspirations led him into choosing a professional path within the pharmacy industry. After receiving his pharmacy degree from Duquesne University and serving as a staff pharmacist at Rite Aid, he was promoted to a medical team focusing on immunization and clinical programming. “What I do in that role is I primarily focus on making Rite Aid’s immunization program successful.
-
Nov 18, 2024 | 
drugtopics.com | Lauren Massaro
With an interest in both medicine and mathematics, Adam J. James, PharmD, found his perfect fit in the pharmacy profession. His career trajectory has evolved from traditional pharmacy practice to a leadership position at Rite Aid, where he is at the forefront of innovation in immunization and clinical programs.
-
Nov 14, 2024 | 
drugtopics.com | Lauren Massaro
On the most recent installment of Over the Counter, Drug Topics was joined by Cassandra Esperant, PharmD, AAHIVP, an HIV clinical pharmacist with the American Academy of HIV Medicine, to celebrate American Pharmacists Month. From her career path as a pharmacist to her work in the community, and more specifically within HIV care, Esperant discussed what it means to be a pharmacist. “As a pharmacist, I have the opportunity to make an impact on each and every one of these patients that I meet.
-
Nov 12, 2024 | 
drugtopics.com | Lauren Massaro
Cassandra Esperant, PharmD, AAHIVP, has made a significant impact on the lives of her patients. Her journey to pharmacy began with a passion for advocacy, which she initially sought to fulfill through a career in law. However, she soon realized that the pharmacy profession offered a unique opportunity to directly improve patient outcomes. As a credentialed HIV clinical pharmacist with the American Academy of HIV Medicine, Esperant balances direct patient care with public health initiatives.
-
Nov 7, 2024 | 
drugtopics.com | Lauren Massaro
Although opioids are highly effective for chronic pain, they pose significant risks of misuse, addiction, and adverse effects. Nonopioid and nonpharmacologic therapies, which are at least as effective as opioids in managing pain for a variety of conditions,1 offer safer alternatives. In response to the opioid crisis, pharmacists are increasingly advocating for nonopioid strategies to optimize pain management and minimize risks.
-
Nov 5, 2024 | 
drugtopics.com | Lauren Massaro
The FDA has approved minocycline hydrochloride extended-release capsules (40 mg; Emrosi), formerly referred to as DFD-29, for the treatment of inflammatory lesions of rosacea in adults, according to a release by developer Journey Medical.1 “With approval from the FDA, Journey Medical is proud to deliver Emrosi, a unique treatment option for the millions of patients in the US suffering from rosacea,” said Claude Maraoui, co-founder, president, and chief executive officer of Journey Medical, in...
-
Nov 4, 2024 | 
drugtopics.com | Lauren Massaro
Starting March 31, 2025, companies participating in the Opioid Analgesic Risk Evaluation and Mitigation Strategy (OA REMS) program must provide pre-paid drug mail-back envelopes to outpatient pharmacies and other dispensers of opioid analgesics upon request, per an approved update to the framework by the FDA.1The update was approved on October 31, 2024, and aims to provide patients and caregivers with a convenient way to safely dispose of any unused or expired opioid analgesics.
